Share chart Acceleron Pharma Inc.
Extended chart
Simple chart
About Acceleron Pharma Inc.
Acceleron Pharma Inc., биофармацевтическая компания, специализируется на открытии, разработке и коммерциализации терапевтических средств для лечения серьезных и редких заболеваний. Он предлагает люспатерсепт-амт для лечения анемии у взрослых пациентов с бета-талассемией под названием REBLOZYL. more detailsIPO date | 2013-09-19 |
---|---|
ISIN | US00434H1086 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.acceleronpharma.com |
Цена ао | 178.75 |
Change price per day: | 0% (178.75) |
---|---|
Change price per week: | 0% (178.75) |
Change price per month: | 0% (178.75) |
Change price per 3 month: | 0% (178.75) |
Change price per half year: | 0% (178.75) |
Change price per year: | 0% (178.75) |
Change price per 3 year: | 0% (178.75) |
Change price per 5 year: | +69.75% (105.3) |
Change price per 10 year: | +454.78% (32.22) |
Change price per year to date: | 0% (178.75) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
---|---|---|---|---|---|---|---|---|---|
27.09.2021 | 27.09.2021 | KANGO SUJAY EVP, Chief Commercial Officer |
Sale | 175 | 875 000 | 5000 | 0 | -0.01 | link |
27.09.2021 | 27.09.2021 | KANGO SUJAY EVP, Chief Commercial Officer |
Purchase | 40.61 | 203 050 | 5000 | 0 | 0.01 | link |
24.09.2021 | 24.09.2021 | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
Sale | 160.38 | 861 241 | 5370 | 0 | -0.01 | link |
24.09.2021 | 24.09.2021 | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
Purchase | 40.64 | 218 237 | 5370 | 0 | 0.01 | link |
23.09.2021 | 24.09.2021 | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
Sale | 160.31 | 3 146 880 | 19630 | 0 | -0.03 | link |
23.09.2021 | 24.09.2021 | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
Purchase | 39.67 | 778 722 | 19630 | 0 | 0.03 | link |
02.07.2021 | 02.07.2021 | Dable Habib J CEO and President |
Sale | 126.97 | 5 356 360 | 42186 | 0 | -0.08 | link |
02.07.2021 | 02.07.2021 | Dable Habib J CEO and President |
Purchase | 35.04 | 1 478 200 | 42186 | 0 | 0.08 | link |
01.07.2021 | 02.07.2021 | Dable Habib J CEO and President |
Sale | 126.73 | 7 326 770 | 57814 | 0 | -0.11 | link |
01.07.2021 | 02.07.2021 | Dable Habib J CEO and President |
Purchase | 35.04 | 2 025 800 | 57814 | 0 | 0.11 | link |
11.12.2020 | 11.12.2020 | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
Sale | 125 | 387 500 | 3100 | 0 | -0.01 | link |
10.12.2020 | 11.12.2020 | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
Sale | 125.12 | 62 560 | 500 | 0 | 0 | link |
09.12.2020 | 11.12.2020 | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
Sale | 125.03 | 484 116 | 3872 | 0 | -0.01 | link |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Habib J. Dable | CEO, Pres & Director | 1.26M | 1969 (56 years) |
Mr. Kevin F. McLaughlin | Sr. VP, CFO & Treasurer | 712.08k | 1956 (69 years) |
Mr. Adam M. Veness Esq. | Sr. VP, Gen. Counsel & Sec. | 690.62k | 1986 (39 years) |
Mr. Sujay R. Kango | Exec. VP & Chief Commercial Officer | 702.16k | 1964 (61 year) |
Dr. Jay T. Backstrom M.D., M.P.H. | Exec. VP of R&D | 850k | 1955 (70 years) |
Dr. Thomas P. Maniatis | Co-Founder, Member of Scientific Advisory Board & Director Emeritus | N/A | 1943 (82 years) |
Dr. Mark Ptashne | Co-Founder and Member of Scientific Advisory Board | N/A | |
Ms. Lisa Wyman | Sr. VP of Technical Operations | N/A | |
Dr. Ravindra Kumar | Chief Scientific Officer & Sr. VP | N/A | 1960 (65 years) |
Mr. Todd James IRC | Sr. VP of Corp. Affairs & Investor Relations | N/A |
Address: United States, Cambridge, 128 Sidney Street - open in Google maps, open in Yandex maps
Website: http://www.acceleronpharma.com
Website: http://www.acceleronpharma.com